605
Views
2
CrossRef citations to date
0
Altmetric
Review

PCSK9 inhibitors and LDL reduction: pharmacology, clinical implications, and future perspectives

&
Pages 567-578 | Received 05 Dec 2017, Accepted 04 Jul 2018, Published online: 18 Jul 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.